MLH1 and non-small cell lung carcinoma: MMR is dysregulated in non-small cell lung cancer, most frequently from mutations in the MSH2 and MLH1 genes, which are responsible for recognition of the mispaired nucleotides, deletions/insertions, and cisplatin-induced interstrand cross-links (36, 37).